NO950920L - Fluorinert vitamin D3-derivat - Google Patents

Fluorinert vitamin D3-derivat

Info

Publication number
NO950920L
NO950920L NO950920A NO950920A NO950920L NO 950920 L NO950920 L NO 950920L NO 950920 A NO950920 A NO 950920A NO 950920 A NO950920 A NO 950920A NO 950920 L NO950920 L NO 950920L
Authority
NO
Norway
Prior art keywords
derivative
fluorinated vitamin
silyl
fluorinated
vitamin
Prior art date
Application number
NO950920A
Other languages
English (en)
Other versions
NO950920D0 (no
NO307782B1 (no
Inventor
Thomas I Doran
Shian-Jan Shiuey
Milan Radoje Uskokovic
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NO950920D0 publication Critical patent/NO950920D0/no
Publication of NO950920L publication Critical patent/NO950920L/no
Publication of NO307782B1 publication Critical patent/NO307782B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
    • C07C39/23—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic, containing six-membered aromatic rings and other rings, with unsaturation outside the aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO950920A 1994-03-11 1995-03-10 Anvendelse av fluorinert vitamin D3-derivat NO307782B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08212453 US5384314B1 (en) 1994-03-11 1994-03-11 1alpha-fluoro-25-hydroxy-16-ene-23-yne-cholecalciferol

Publications (3)

Publication Number Publication Date
NO950920D0 NO950920D0 (no) 1995-03-10
NO950920L true NO950920L (no) 1995-09-12
NO307782B1 NO307782B1 (no) 2000-05-29

Family

ID=22791087

Family Applications (1)

Application Number Title Priority Date Filing Date
NO950920A NO307782B1 (no) 1994-03-11 1995-03-10 Anvendelse av fluorinert vitamin D3-derivat

Country Status (22)

Country Link
US (1) US5384314B1 (no)
EP (1) EP0671387B1 (no)
JP (1) JP2659345B2 (no)
KR (1) KR100360732B1 (no)
CN (1) CN1051227C (no)
AT (1) ATE165595T1 (no)
AU (1) AU687972B2 (no)
BR (1) BR9501035A (no)
CA (1) CA2141652C (no)
CZ (1) CZ288793B6 (no)
DE (1) DE69502223T2 (no)
DK (1) DK0671387T3 (no)
ES (1) ES2116634T3 (no)
FI (1) FI112323B (no)
HU (1) HU219906B (no)
IL (1) IL112887A0 (no)
NO (1) NO307782B1 (no)
NZ (1) NZ270624A (no)
PH (1) PH31333A (no)
PL (1) PL179120B1 (no)
RU (1) RU2142803C1 (no)
ZA (1) ZA951798B (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5830885A (en) * 1992-03-12 1998-11-03 The Johns Hopkins University Antiproliferative vitamin D3 hybrids
US5696103A (en) * 1995-11-17 1997-12-09 Syntex (U.S.A.) Inc. Method for treating osteoporosis
SG70010A1 (en) * 1996-05-23 2000-01-25 Hoffmann La Roche Fluorinated vitamin d3 analogs
NO971934L (no) * 1996-05-23 1997-11-24 Hoffmann La Roche Flourinerte vitamin D3 -analoger
US5939408A (en) 1996-05-23 1999-08-17 Hoffman-La Roche Inc. Vitamin D3 analogs
US5840718A (en) * 1997-03-06 1998-11-24 Hoffmann-La Roche Inc. 22-epimeric-1,25-dihydroxy-16,22,23-triene-cholecalciferol
US6008209A (en) * 1997-04-28 1999-12-28 Hoffmann-La Roche Inc. Method of using vitamin D3 analogs with bis C-20 side chains
JPH10316652A (ja) * 1997-05-02 1998-12-02 Duphar Internatl Res Bv １６−デヒドロビタミンｄ化合物の製造方法
US5872113A (en) * 1997-05-16 1999-02-16 Syntex (U.S.A.) Inc. Fluorinated vitamin D3 analogs
US5919986A (en) * 1997-10-17 1999-07-06 Hoffmann-La Roche Inc. D-homo vitamin D3 derivatives
WO2000051554A2 (en) * 1999-03-05 2000-09-08 Johns Hopkins University Regulating skin appearance and composition with a fluorinated vitamin d3 analog compound
DE19935771A1 (de) * 1999-07-23 2001-02-01 Schering Ag Neue Vitamin D-Derivate mit cyclischen Substrukturen in den Seitenketten, Verfahren und Zwischenprodukte zu ihrer Herstellung und die Verwendung zur Herstellung von Arzneimitteln
DE10211555A1 (de) * 2002-03-15 2003-10-02 Imtm Inst Fuer Medizintechnolo Verwendung der Inhibitoren von Enzymen mit Aktivitäten der Aminopeptidase N und/oder der Dipeptidylpeptidase IV und pharmazeutischen Zubereitungen daraus zur Therapie und Prävention dermatologischer Erkrankungen mit sebozytärer Hyperproliferation und veränderten Differenzierungszuständen

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4188345A (en) * 1978-07-26 1980-02-12 Wisconsin Alumni Research Foundation Fluorovitamin D compounds and processes for their preparation
JPS6340975A (ja) * 1986-08-05 1988-02-22 Mitsubishi Electric Corp 階調補正方式
US5087619A (en) * 1988-01-20 1992-02-11 Hoffman-La Roche Inc. Vitamin D3 analogs
US5145846A (en) * 1988-01-20 1992-09-08 Hoffmann-La Roche Inc. Vitamin D3 analogs
GB8915770D0 (en) * 1989-07-10 1989-08-31 Leo Pharm Prod Ltd Chemical compounds
GB9004544D0 (en) * 1990-03-01 1990-04-25 Leo Pharm Prod Ltd Novel treatment ii
GB9017890D0 (en) * 1990-08-15 1990-09-26 Leo Pharm Prod Ltd Chemical compounds i
ATE141914T1 (de) * 1992-05-20 1996-09-15 Hoffmann La Roche Fluorierte analoge vitamins d3

Also Published As

Publication number Publication date
RU2142803C1 (ru) 1999-12-20
PH31333A (en) 1998-07-06
ATE165595T1 (de) 1998-05-15
ZA951798B (en) 1996-08-14
US5384314B1 (en) 1997-08-05
KR100360732B1 (ko) 2003-03-04
CA2141652A1 (en) 1995-09-12
BR9501035A (pt) 1995-10-31
FI951134A0 (fi) 1995-03-10
ES2116634T3 (es) 1998-07-16
PL179120B1 (pl) 2000-07-31
JPH07258208A (ja) 1995-10-09
AU687972B2 (en) 1998-03-05
RU95103438A (ru) 1997-02-10
DE69502223D1 (de) 1998-06-04
EP0671387A1 (en) 1995-09-13
CZ288793B6 (cs) 2001-09-12
AU1364495A (en) 1995-09-21
CN1051227C (zh) 2000-04-12
HU9500666D0 (en) 1995-04-28
US5384314A (en) 1995-01-24
DK0671387T3 (da) 1998-10-07
CA2141652C (en) 2006-05-09
JP2659345B2 (ja) 1997-09-30
FI951134A (fi) 1995-09-12
HUT70746A (en) 1995-10-30
CZ63295A3 (en) 1995-11-15
KR950032046A (ko) 1995-12-20
FI112323B (fi) 2003-11-28
IL112887A0 (en) 1995-06-29
NO950920D0 (no) 1995-03-10
EP0671387B1 (en) 1998-04-29
NO307782B1 (no) 2000-05-29
DE69502223T2 (de) 1998-10-29
HU219906B (hu) 2001-09-28
CN1112918A (zh) 1995-12-06
PL307629A1 (en) 1995-09-18
NZ270624A (en) 1996-06-25

Similar Documents

Publication Publication Date Title
NO950920L (no) Fluorinert vitamin D3-derivat
DE69408516D1 (de) Vitamin-D3-Analoge
WO1998045241A3 (en) Lutein esters having high bioavailability
MXPA04005376A (es) Composiciones farmaceuticas y sus usos.
RS52625B (en) FLUORO SUBSTITUTED OMEGA-CARBOXYARYL DIPHENYL UREA FOR TREATMENT AND PREVENTION OF DISEASES AND DISEASES
DE69612003D1 (de) Substituierte benzolaktamverbindungen als substanz-p-antagonisten
CA2390295A1 (en) A method for chemoprevention of prostate cancer
AU6894800A (en) Caspase inhibitors and uses thereof
BRPI0415179A (pt) derivados de amida como ligandos de canal de ìon e composições farmacêuticas e métodos de empregar as mesmas
ES2136252T3 (es) Tratamiento de enfermedades causadas por trastornos de la glandula sebacea mediante el uso de inhibidores de acil coa colesterol acil transferasa.
DE60214359D1 (en) Stickstoffbasierte camptothecin-derivate
YU19997A (sh) Analozi fluorovanog vitamina d3
SG148215A1 (en) Methods of protecting against radiation using flagellin
AU2002308337A1 (en) Compounds and methods for inhibiting axillary malodour
ES2134313T3 (es) Utilizacion de derivados de pregnano para el tratamiento de tumores.
ES2164454T3 (es) Nuevos compuestos derivados de acido alquilendiamina di o tri-acetico, su procedimiento de preparacion, su utilizacion en composiciones cosmeticas y farmaceuticas y composiciones que los contienen.
AU2003207024A1 (en) Spermidine derivatives for the treatment of chronic neurodegenerative diseases
BR0214244A (pt) Uso de uma ascomicina
MD940041A (ro) Derivaţi ai acizilor hidroxamici, compoziţie pe baza lor, procedee de combatere a micetelor fitopatogene şi de prevenire a infectării

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN SEPTEMBER 2002